In section Releases

West Pharmaceutical Services Schedules September Investor Presentations

Executives from Exton-based West Pharmaceutical Services will outline the company’s strategic trajectory at two major healthcare forums this September. The manufacturer, which reported $3.07 billion in net sales for fiscal 2025, intends to discuss its role in the global injectable drug delivery market during back-to-back industry conferences.

West Pharmaceutical Services Schedules September Investor Presentations

The company’s leadership team is slated to present at the Wells Fargo Annual Healthcare Conference in Everett, Massachusetts, on September 10 at 8:45 a.m. EDT. This appearance will be followed by a presentation at the Morgan Stanley Annual Global Healthcare Conference in New York on September 14 at 8:30 a.m. EDT. Investors and industry analysts can access live webcasts through the company’s portal, with archived replays remaining available for 90 days following each session.

West currently operates a network of 50 sites worldwide, including 26 manufacturing facilities, and produces over 41 billion components and devices annually. As a component of the S&P 500, the firm remains a critical link for both established pharmaceutical companies and emerging drug developers focused on the containment and administration of injectable therapies.

Share:on TelegramXFacebook

Subscribe to our newsletter

Once a week — the best stories from our editors, no ads or push notifications. Delivered Sunday morning.

Comments (0)

Leave a comment

No comments yet. Be the first!